1
|
Genetic substrates of bipolar disorder risk in Latino families. Mol Psychiatry 2023; 28:154-167. [PMID: 35948660 DOI: 10.1038/s41380-022-01705-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/30/2021] [Revised: 06/22/2022] [Accepted: 07/07/2022] [Indexed: 01/07/2023]
Abstract
Genetic studies of bipolar disorder (BP) have been conducted in the Latin American population, to date, in several countries, including Mexico, the United States, Costa Rica, Colombia, and, to a lesser extent, Brazil. These studies focused primarily on linkage-based designs utilizing families with multiplex cases of BP. Significant BP loci were identified on Chromosomes 18, 5 and 8, and fine mapping suggested several genes of interest underlying these linkage peaks. More recently, studies in these same pedigrees yielded significant linkage loci for BP endophenotypes, including measures of activity, sleep cycles, and personality traits. Building from findings in other populations, candidate gene association analyses in Latinos from Mexican and Central American ancestry confirmed the role of several genes (including CACNA1C and ANK3) in conferring BP risk. Although GWAS, methylation, and deep sequencing studies have only begun in these populations, there is evidence that CNVs and rare SNPs both play a role in BP risk of these populations. Large segments of the Latino populations in the Americas remain largely unstudied regarding BP genetics, but evidence to date has shown that this type of research can be successfully conducted in these populations and that the genetic underpinnings of BP in these cohorts share at least some characteristics with risk genes identified in European and other populations.
Collapse
|
2
|
Lee KY, Lee BD, Park JM, Lee YM, Moon E, Jeong HJ, Kim SY, Suh H, Chung YI, Kim SC. Investigation of Maternal Effects, Maternal-Fetal Interactions, and Parent-of-Origin Effects (Imprinting) for Candidate Genes Positioned on Chromosome 18q21, in Probands with Schizophrenia and their First-Degree Relatives. Psychiatry Investig 2019; 16:450-458. [PMID: 31247704 PMCID: PMC6603700 DOI: 10.30773/pi.2019.04.12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/25/2018] [Accepted: 04/12/2019] [Indexed: 12/04/2022] Open
Abstract
OBJECTIVE A popular design for the investigation of such effects, including effects of parent-of-origin (imprinting), maternal genotype, and maternal-fetal genotype interactions, is to collect deoxyribonucleic acid (DNA) from affected offspring and their mothers and to compare with an appropriate control sample. We investigate the effects of estimation of maternal, imprinting and interaction effects using multimodal modeling using parents and their offspring with schizophrenia in Korean population. METHODS We have recruited 27 probands (with schizophrenia) with their parents and siblings whenever possible. We analyzed 20 SNPs of 7 neuronal genes in chromosome 18. We used EMIM analysis program for the estimation of maternal, imprinting and interaction effects using multimodal modeling. RESULTS Of analyzed 20 single nucleotide polymorphisms (SNPs), significant SNP (rs 2276186) was suggested in EMIM analysis for child genetics effects (p=0.0225438044) and child genetic effects allowing for maternal genetic effects (p=0.0209453210) with very stringent multiple comparison Bonferroni correction. CONCLUSION Our results are the pilot study for epigenetic study in mental disorder and help to understanding and use of EMIM statistical genetics analysis program with many limitations including small pedigree numbers.
Collapse
Affiliation(s)
- Kang Yoon Lee
- Department of Psychiatry, Pusan National University Hospital, Busan, Republic of Korea.,Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
| | - Byung Dae Lee
- Department of Psychiatry, Pusan National University Hospital, Busan, Republic of Korea.,Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.,Department of Psychiatry, Pusan National University College of Medicine, Busan, Republic of Korea
| | - Je Min Park
- Department of Psychiatry, Pusan National University Hospital, Busan, Republic of Korea.,Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.,Department of Psychiatry, Pusan National University College of Medicine, Busan, Republic of Korea
| | - Young Min Lee
- Department of Psychiatry, Pusan National University Hospital, Busan, Republic of Korea.,Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.,Department of Psychiatry, Pusan National University College of Medicine, Busan, Republic of Korea
| | - Eunsoo Moon
- Department of Psychiatry, Pusan National University Hospital, Busan, Republic of Korea.,Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.,Department of Psychiatry, Pusan National University College of Medicine, Busan, Republic of Korea
| | - Hee Jeong Jeong
- Department of Psychiatry, Pusan National University Hospital, Busan, Republic of Korea.,Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
| | - Soo Yeon Kim
- Department of Psychiatry, Pusan National University Hospital, Busan, Republic of Korea.,Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
| | - Hwagyu Suh
- Department of Psychiatry, Pusan National University Hospital, Busan, Republic of Korea.,Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
| | - Young In Chung
- Department of Psychiatry, Pusan National University College of Medicine, Busan, Republic of Korea
| | - Seung Chul Kim
- Department of Obstetrics and Gynecology, Pusan National University Hospital, Busan, Republic of Korea
| |
Collapse
|
3
|
Quezada H, Guzmán-Ortiz AL, Díaz-Sánchez H, Valle-Rios R, Aguirre-Hernández J. Omics-based biomarkers: current status and potential use in the clinic. ACTA ACUST UNITED AC 2017. [DOI: 10.1016/j.bmhime.2017.11.030] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
|
4
|
Omics-based biomarkers: current status and potential use in the clinic. BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO 2017; 74:219-226. [DOI: 10.1016/j.bmhimx.2017.03.003] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2017] [Accepted: 03/17/2017] [Indexed: 12/20/2022] Open
|
5
|
Cho MJ, Lee BD, Kim C. Pilot study for family-based association analysis of schizophrenia in a Korean population: Analysis for candidate genes positionally on chromosome 18q21. Asia Pac Psychiatry 2015; 7:268-75. [PMID: 25504777 DOI: 10.1111/appy.12167] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/14/2014] [Accepted: 10/27/2014] [Indexed: 11/28/2022]
Abstract
INTRODUCTION Schizophrenia is the most devastating mental illness that causes severe deterioration in social and occupational functioning. This is a pilot study for family-based association analysis of schizophrenia in a Korean population to search candidate genes functionally relevant and positionally on chromosome 18. METHODS We have recruited 27 probands (with psychosis) with their parents and siblings whenever possible. We analyzed 20 SNPs (Single Nucleotide Polymorphism) of seven neuronal genes in chromosome 18 for DNA samples that was checked for the data quality and genotype error. For testing of association, we performed family-based association tests analyses with each individual SNP, using the phenotype of psychosis. And then, we performed family-based association tests haplotype analyses with each individual SNP, using the phenotype of psychosis. Finally, we performed linkage disequilibrium analyses for the phenotype of schizophrenia. RESULTS We found one significant SNPs of one neuronal gene in chromosome 18 (P value < 0.05) for the qualitative phenotype of psychosis (rs1893490:MAPK4). We also found significant haplotypes of four SNPs in mitogen-activated protein kinase 4 (MAPK4) gene of chromosome 18 (P value < 0.1) for the phenotype of psychosis (rs1893490-rs3892158-rs3752088-rs3794899). Two SNPS within the MAPK4 gene (rs3794899, rs3794901), plus SNPs within the malic enzyme 2 (rs685533, rs12277), and SMAD4 genes (rs8096092, rs2298617) were in strong linkage disequilibrium with each other (D' > 0.60). DISCUSSION The present findings provide convergent evidence (fine mapping of a chromosomal locus 18q21 associated with schizophrenia) suggesting that a specific MAPK4 could be a candidate gene for causing a spectrum of schizophrenia phenotype.
Collapse
Affiliation(s)
- Min Jung Cho
- Department of Pediatrics, Pusan National University Hospital, Busan, South Korea.,Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
| | - Byung Dae Lee
- Department of Psychiatry, Pusan National University Hospital, Busan, South Korea.,Department of Psychiatry, Pusan National University College of Medicine, Kyungnam, Republic of Korea.,Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
| | - Choongrak Kim
- Department of Statistics, Pusan National University, Busan, Republic of Korea
| |
Collapse
|
6
|
Lee BD, Park JM, Lee YM, Moon ES, Jeong HJ, Chung YI, Rim HD. A Pilot Study for Discovering Candidate Genes of Chromosome 18q21 in Methamphetamine Abusers: Case-control Association Study. CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE 2014; 12:54-64. [PMID: 24851122 PMCID: PMC4022767 DOI: 10.9758/cpn.2014.12.1.54] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/15/2013] [Revised: 12/14/2013] [Accepted: 03/01/2014] [Indexed: 11/18/2022]
Abstract
Objective It was previously suggested that the malic enzyme 2 (ME2) as the candidate gene for psychosis in fine mapping of chromosome 18q21. Chromosome 18q21 is also one of the possible regions that can contribute to addiction. Methods We performed a pilot study for discovering candidate gene of chromosome 18q21 in the methamphetamine abusers for elucidating the candidate gene for methamphetamine addiction leading to psychosis. We have selected 30 unrelated controls (16 males, 14 females; age=59.8±10.4) and 37 male methamphetamine abusers (age=43.3±7.8). We analyzed 20 single nucleotide polymorphisms (SNPs) of 7 neuronal genes in chromosome 18q21 for DNA samples that was checked for the data quality and genotype error. The association between the case-control status and each individual SNP was measured using multiple logistic regression models (adjusting for age and sex as covariates). And we controlled false discovery rate (FDR) to deal with multiple testing problem. Results We found 3 significant SNPs of 2 genes in chromosome 18q21 (p-value<0.05; adjusting for age as covariate) in methamphetamine abusers compared to controls. We also found 2 significant SNPs of 1 gene (p-value<0.05; adjusting for age and sex as covariates) (rs3794899, rs3794901:MAPK4). Two SNPs in MAPK4 gene were significant in both statistical groups. Conclusion MAPK4, the gene for mitogen-activated protein kinase 4, is one of the final 6 candidate genes including ME2 in 18q12-21 in our previous finemapping for psychosis. Our results suggest that MAPK4 can be a candidate gene that contribute to the methamphetamine addiction leading to psychosis.
Collapse
Affiliation(s)
- Byung Dae Lee
- Department of Psychiatry, Medical Research Institute, Pusan National University Hospital, Busan, Korea. ; Department of Psychiatry, Pusan National University College of Medicine, Yangsan, Korea
| | - Je Min Park
- Department of Psychiatry, Medical Research Institute, Pusan National University Hospital, Busan, Korea. ; Department of Psychiatry, Pusan National University College of Medicine, Yangsan, Korea
| | - Young Min Lee
- Department of Psychiatry, Medical Research Institute, Pusan National University Hospital, Busan, Korea. ; Department of Psychiatry, Pusan National University College of Medicine, Yangsan, Korea
| | - Eun Soo Moon
- Department of Psychiatry, Medical Research Institute, Pusan National University Hospital, Busan, Korea. ; Department of Psychiatry, Pusan National University College of Medicine, Yangsan, Korea
| | - Hee Jeong Jeong
- Department of Psychiatry, Medical Research Institute, Pusan National University Hospital, Busan, Korea. ; Department of Psychiatry, Pusan National University College of Medicine, Yangsan, Korea
| | - Young In Chung
- Department of Psychiatry, Medical Research Institute, Pusan National University Hospital, Busan, Korea. ; Department of Psychiatry, Pusan National University College of Medicine, Yangsan, Korea
| | - Hyo Deog Rim
- Department of Psychiatry, Kyungpook National University Hospital, Daegu, Korea
| |
Collapse
|
7
|
Del Zompo M, Deleuze JF, Chillotti C, Cousin E, Niehaus D, Ebstein RP, Ardau R, Macé S, Warnich L, Mujahed M, Severino G, Dib C, Jordaan E, Murad I, Soubigou S, Koen L, Bannoura I, Rocher C, Laurent C, Derock M, Faucon Biguet N, Mallet J, Meloni R. Association study in three different populations between the GPR88 gene and major psychoses. Mol Genet Genomic Med 2013; 2:152-9. [PMID: 24689078 PMCID: PMC3960057 DOI: 10.1002/mgg3.54] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2013] [Revised: 11/06/2013] [Accepted: 11/12/2013] [Indexed: 12/14/2022] Open
Abstract
GPR88, coding for a G protein-coupled orphan receptor that is highly represented in the striatum, is a strong functional candidate gene for neuropsychiatric disorders and is located at 1p22-p21, a chromosomal region that we have previously linked to bipolar disorder (BD) in the Sardinian population. In order to ascertain the relevance of GPR88 as a risk factor for psychiatric diseases, we performed a genetic association analysis between GPR88 and BD in a sample of triads (patient and both parents) recruited in the Sardinian and the Palestinian population as well as between GPR88 and schizophrenia (SZ) in triads from the Xhosa population in South Africa. We found a positive association between GPR88 and BD in the Sardinian and Palestinian triads. Moreover, we found a positive association between GPR88 and SZ in triads from the Xhosa population in South Africa. When these results were corrected for multiple testing, the association between GPR88 and BD was maintained in the Palestinian population. Thus, these results suggest that GPR88 deserves consideration as a candidate gene for psychiatric diseases and requires to be further investigated in other populations.
Collapse
Affiliation(s)
- Maria Del Zompo
- Section of Neurosciences and Clinical Psychopharmacology, Department of Biomedical Sciences, University of Cagliari Cagliari, Italy ; Unit of Clinical Pharmacology, Teaching Hospital of Cagliari, AOUCA Cagliari, Italy
| | | | - Caterina Chillotti
- Unit of Clinical Pharmacology, Teaching Hospital of Cagliari, AOUCA Cagliari, Italy
| | | | - Dana Niehaus
- Department of Psychiatry, Faculty of Health Sciences, Stellenbosch University Stellenbosch, South Africa
| | | | - Raffaella Ardau
- Unit of Clinical Pharmacology, Teaching Hospital of Cagliari, AOUCA Cagliari, Italy
| | | | - Louise Warnich
- Department of Genetics, Stellenbosch University Stellenbosch, South Africa
| | - Mustafa Mujahed
- Palestinian Research Center for Genetics of Mental Disorders, Bethlehem Mental Hospital Bethlehem, Palestine
| | - Giovanni Severino
- Section of Neurosciences and Clinical Psychopharmacology, Department of Biomedical Sciences, University of Cagliari Cagliari, Italy
| | | | - Esme Jordaan
- Biostatistics Unit, Medical Research Council Bellville, South Africa
| | - Ibrahim Murad
- Palestinian Research Center for Genetics of Mental Disorders, Bethlehem Mental Hospital Bethlehem, Palestine
| | | | - Liezl Koen
- Department of Psychiatry, Faculty of Health Sciences, Stellenbosch University Stellenbosch, South Africa
| | - Issam Bannoura
- Palestinian Research Center for Genetics of Mental Disorders, Bethlehem Mental Hospital Bethlehem, Palestine
| | | | - Claudine Laurent
- Department of Child and Adolescent Psychiatry, Pierre and Marie Curie Faculty of Medicine Paris, France
| | | | - Nicole Faucon Biguet
- Department of Biotechnology and Biotherapy C.R.I.C.M. UPMC/INSERM UMR_S975/CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière (ICM) GHU Pitié-Salpêtrière, Paris, France
| | - Jacques Mallet
- Department of Biotechnology and Biotherapy C.R.I.C.M. UPMC/INSERM UMR_S975/CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière (ICM) GHU Pitié-Salpêtrière, Paris, France
| | - Rolando Meloni
- Department of Biotechnology and Biotherapy C.R.I.C.M. UPMC/INSERM UMR_S975/CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière (ICM) GHU Pitié-Salpêtrière, Paris, France
| |
Collapse
|
8
|
Ceulemans S, De Zutter S, Heyrman L, Norrback KF, Nordin A, Nilsson LG, Adolfsson R, Del-Favero J, Claes S. Evidence for the involvement of the glucocorticoid receptor gene in bipolar disorder in an isolated northern Swedish population. Bipolar Disord 2011; 13:614-23. [PMID: 22085474 DOI: 10.1111/j.1399-5618.2011.00960.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
OBJECTIVES Dysfunction of the hypothalamus-pituitary-adrenal (HPA) axis is one of the most consistent findings in the pathophysiology of mood disorders. The potential role of genes related to HPA axis function has been investigated extensively in major depression. However, in bipolar disorder (BPD) such studies are scarce. We performed a systematic HapMap-based association study of six genes crucial for HPA axis function in relation to BPD. METHODS Haplotype tagging single nucleotide polymorphisms (htSNPs) were selected in order to identify all haplotypes with a frequency of more than 1% in the genes encoding the glucocorticoid receptor (GR), mineralocorticoid receptor (MR), corticotrophin releasing hormone receptor 1 (CRH-R1) and 2 (CRH-R2), CRH binding protein (CRH-BP), and FK binding protein 5 (FKBP5). This resulted in a total selection of 225 SNPs that were genotyped and analyzed in 309 BPD patients and 364 matched control individuals all originating from an isolated northern Swedish population. RESULTS Consistent evidence for an association with BPD was found for NR3C1, the gene encoding GR. Almost all SNPs in two adjacent haplotype blocks contributed to the positive signal, comprised of significant single marker, sliding window, and haplotype-specific p-values. All these results point to a moderately frequent (10-15%) susceptibility haplotype covering the entire coding region and 3' untranslated region (UTR) of NR3C1. CONCLUSIONS This study contributes to the growing evidence for a role of the glucocorticoid receptor gene (NR3C1) in vulnerability to mood disorders, and BPD in particular, and warrants further in vitro investigation of the at-risk haplotypes with respect to disease etiology. However, this association might be restricted to this specific population, as it is observed in a rather small sample from an isolated population without replication, and data from large meta-analyses for genome-wide association studies in BPD do not show the GR as a very strong candidate.
Collapse
Affiliation(s)
- Shana Ceulemans
- Applied Molecular Genomics Group, Department of Molecular Genetics, VIB, Belgium
| | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Del Zompo M, Severino G, Ardau R, Chillotti C, Piccardi M, Dib C, Muzard G, Soubigou S, Derock M, Fournel R, Vaubien Y, Roche S, Bowen-Squires L, Génin E, Cousin E, Deleuze JF, Biguet NF, Mallet J, Meloni R. Genome-scan for bipolar disorder with sib-pair families in the Sardinian population: a new susceptibility locus on chromosome 1p22-p21? Am J Med Genet B Neuropsychiatr Genet 2010; 153B:1200-8. [PMID: 20468074 DOI: 10.1002/ajmg.b.31092] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
The discovery of the genetic factors implicated in the predisposition to complex diseases may greatly profit from genetic studies in isolated populations. In this perspective, we performed a genome-wide scan using 507 microsatellite markers, with an average interval size of 7.6 cM, on a sample of 88 nuclear families with at least two affected sibs with bipolar disorder recruited in the Sardinian population. An initial analysis yielded non-parametric linkage exceeding 3.4 with P-values <0.0003 at two adjacent markers, D1S206 and D1S435 in the 1p22-p21 chromosomal region. Moreover, positive linkage ranging between 2.0 and 3.0 was obtained for other loci in several cases in regions that have already been linked to predisposition to bipolar disorder, such as 5p15.33, 8q24.13, and 11q14.3. A subsequent analysis of the 1p22-p21 region using the same set of families and a dense panel of 20 new microsatellite markers, spaced at 1.2 cM on average, reinforced the finding of suggestive linkage for this region. Interestingly, NPL values above 2.1 and P-values <0.02 were obtained for a cluster of 10 markers comprising D1S435. Thus, this study suggests that the 1p22-p21 region may contain a new locus participating to the genetic susceptibility to bipolar disorder and reproduces positive linkage for several other loci already implicated in this pathology. Since the Sardinian population presents a peculiar genetic homogeneity, these results may pave the way to further studies for replication in this population contributing to the rapid discovery of the genetic factors predisposing to bipolar disorder.
Collapse
Affiliation(s)
- Maria Del Zompo
- Center of Clinical Psychopharmacology, Department of Neurosciences B.B. Brodie, University of Cagliari, Via Ospedale 46, Cagliari, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Ruiz-Narváez EA, Bare L, Arellano A, Catanese J, Campos H. West African and Amerindian ancestry and risk of myocardial infarction and metabolic syndrome in the Central Valley population of Costa Rica. Hum Genet 2010; 127:629-38. [PMID: 20213474 DOI: 10.1007/s00439-010-0803-x] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2009] [Accepted: 02/09/2010] [Indexed: 01/28/2023]
Abstract
Genetic ancestry and environmental factors may contribute to the ethnic differences in risk of coronary heart disease (CHD), metabolic syndrome (MS) or its individual components. The population of the Central Valley of Costa Rica offers a unique opportunity to assess the role of genetic ancestry in these chronic diseases because it derived from the admixture of a relatively small number of founders of Southern European, Amerindian, and West African origin. We aimed to determine whether genetic ancestry is associated with risk of myocardial infarction (MI), MS and its individual components in the Central Valley of Costa Rica. We genotyped 39 ancestral informative markers in cases (n = 1,998) with a first non-fatal acute MI and population-based controls (n = 1,998) matched for age, sex, and area of residence, to estimate individual ancestry proportions. Odds ratios (ORs) and 95% confidence intervals (95% CI) were estimated using conditional (MI) and unconditional (MS and its components) logistic regression adjusting for relevant confounders. Mean individual ancestry proportions in cases and controls were 57.5 versus 57.8% for the Southern European, 38.4 versus 38.3% for the Amerindian and 4.1 versus 3.8% for the West African ancestry. Compared with Southern European ancestry, each 10% increase in West African ancestry was associated with a 29% increase in MI, OR (95% CI) = 1.29 (1.07, 1.56), and with a 30% increase on the risk of hypertension, OR (95% CI) = 1.30 (1.00, 1.70). Each 10% increase in Amerindian ancestry was associated with a 14% increase on the risk of MS, OR (95% CI) = 1.14 (1.00, 1.30), and 20% increase on the risk of impaired fasting glucose, OR (95% CI) = 1.20 (1.01, 1.42). These results show that the high variability of admixture proportions in the Central Valley population offers a unique opportunity to uncover the genetic basis of ethnic differences on the risk of disease.
Collapse
|
11
|
Choi Y, Wijsman EM, Weir BS. Case-control association testing in the presence of unknown relationships. Genet Epidemiol 2010; 33:668-78. [PMID: 19333967 DOI: 10.1002/gepi.20418] [Citation(s) in RCA: 66] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
Genome-wide association studies result in inflated false-positive results when unrecognized cryptic relatedness exists. A number of methods have been proposed for testing association between markers and disease with a correction for known pedigree-based relationships. However, in most case-control studies, relationships are generally unknown, yet the design is predicated on the assumption of at least ancestral relatedness among cases. Here, we focus on adjusting cryptic relatedness when the genealogy of the sample is unknown, particularly in the context of samples from isolated populations where cryptic relatedness may be problematic. We estimate cryptic relatedness using maximum-likelihood methods and use a corrected chi(2) test with estimated kinship coefficients for testing in the context of unknown cryptic relatedness. Estimated kinship coefficients characterize precisely the relatedness between truly related people, but are biased for unrelated pairs. The proposed test substantially reduces spurious positive results, producing a uniform null distribution of P-values. Especially with missing pedigree information, estimated kinship coefficients can still be used to correct non-independence among individuals. The corrected test was applied to real data sets from genetic isolates and created a distribution of P-value that was close to uniform. Thus, the proposed test corrects the non-uniform distribution of P-values obtained with the uncorrected test and illustrates the advantage of the approach on real data.
Collapse
Affiliation(s)
- Yoonha Choi
- Department of Biostatistics, University of Washington, Seattle, 98195-7720, USA
| | | | | |
Collapse
|
12
|
Genome-wide linkage analysis of serum creatinine in three isolated European populations. Kidney Int 2009; 76:297-306. [DOI: 10.1038/ki.2009.135] [Citation(s) in RCA: 60] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
13
|
Neuropsychological performance as endophenotypes in extended schizophrenia families from the Central Valley of Costa Rica. Psychiatr Genet 2009; 19:45-52. [PMID: 19125108 DOI: 10.1097/ypg.0b013e3283202816] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVE The understanding of complex heritable psychiatric disorders such as schizophrenia could be clarified by examining endophenotypes within genetically isolated populations, such as the one found in the Central Valley of Costa Rica. The reduction of familial variability within a sample could allow the relationship between the cognitive and symptomatic manifestations of the illness and the genetic underpinnings to become more observable. This study investigates the neuropsychological test performances of 41 family members from four extended multiplex families within the Spanish origin population of the Central Valley of Costa Rica as potential endophenotypes for genetic studies. METHODS Individuals with a diagnosis of schizophrenia or schizoaffective disorder were compared with unaffected relatives and 15 unrelated controls with no family history of schizophrenia. RESULTS Although the sample size is small, the results confirm previous reports in the literature of deficits in working memory, executive function, processing speed, and verbal fluency in individuals with schizophrenia compared with controls and intermediate performance in nonpsychotic family members compared with controls. We also found several suggestive quantitative cognitive trait loci with log of the odds greater than 1.75. CONCLUSION These findings suggest that the cognitive deficits in schizophrenia are consistent aspects of the illness, although their usefulness as endophenotypes for genetic studies remains unclear.
Collapse
|
14
|
Bellis C, Cox HC, Dyer TD, Charlesworth JC, Begley KN, Quinlan S, Lea RA, Heath SC, Blangero J, Griffiths LR. Linkage mapping of CVD risk traits in the isolated Norfolk Island population. Hum Genet 2008; 124:543-52. [PMID: 18975005 DOI: 10.1007/s00439-008-0580-y] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2008] [Accepted: 10/21/2008] [Indexed: 01/04/2023]
Abstract
To understand the underlying genetic architecture of cardiovascular disease (CVD) risk traits, we undertook a genome-wide linkage scan to identify CVD quantitative trait loci (QTLs) in 377 individuals from the Norfolk Island population. The central aim of this research focused on the utilization of a genetically and geographically isolated population of individuals from Norfolk Island for the purposes of variance component linkage analysis to identify QTLs involved in CVD risk traits. Substantial evidence supports the involvement of traits such as systolic and diastolic blood pressures, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol, body mass index and triglycerides as important risk factors for CVD pathogenesis. In addition to the environmental influences of poor diet, reduced physical activity, increasing age, cigarette smoking and alcohol consumption, many studies have illustrated a strong involvement of genetic components in the CVD phenotype through family and twin studies. We undertook a genome scan using 400 markers spaced approximately 10 cM in 600 individuals from Norfolk Island. Genotype data was analyzed using the variance components methods of SOLAR. Our results gave a peak LOD score of 2.01 localizing to chromosome 1p36 for systolic blood pressure and replicated previously implicated loci for other CVD relevant QTLs.
Collapse
Affiliation(s)
- C Bellis
- Genomics Research Centre, Griffith Institute for Health and Medical Research, Griffith University, Gold Coast PMB 50, GCMC Bundall 9726, Gold Coast, Australia.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Abstract
Bipolar disorder, especially the most severe type (type I), has a strong genetic component. Family studies suggest that a small number of genes of modest effect are involved in this disorder. Family-based studies have identified a number of chromosomal regions linked to bipolar disorder, and progress is currently being made in identifying positional candidate genes within those regions, À number of candidate genes have also shown evidence of association with bipolar disorder, and genome-wide association studies are now under way, using dense genetic maps. Replication studies in larger or combined datasets are needed to definitively assign a role for specific genes in this disorder. This review covers our current knowledge of the genetics of bipolar disorder, and provides a commentary on current approaches used to identify the genes involved in this complex behavioral disorder.
Collapse
Affiliation(s)
- Michael A Escamilla
- University of Texas Health Science Center at San Antonio, South Texas Medical Genetics Research Center, 1214 Schunior St, Edinburg, TX 78539, USA.
| | | |
Collapse
|
16
|
Identity-by-descent estimation and mapping of qualitative traits in large, complex pedigrees. Genetics 2008; 179:1577-90. [PMID: 18622032 DOI: 10.1534/genetics.108.089912] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023] Open
Abstract
Computing identity-by-descent sharing between individuals connected through a large, complex pedigree is a computationally demanding task that often cannot be done using exact methods. What I present here is a rapid computational method for estimating, in large complex pedigrees, the probability that pairs of alleles are IBD given the single-point genotype data at that marker for all individuals. The method can be used on pedigrees of essentially arbitrary size and complexity without the need to divide the individuals into separate subpedigrees. I apply the method to do qualitative trait linkage mapping using the nonparametric sharing statistic S(pairs). The validity of the method is demonstrated via simulation studies on a 13-generation 3028-person pedigree with 700 genotyped individuals. An analysis of an asthma data set of individuals in this pedigree finds four loci with P-values <10(-3) that were not detected in prior analyses. The mapping method is fast and can complete analyses of approximately 150 affected individuals within this pedigree for thousands of markers in a matter of hours.
Collapse
|
17
|
Kim TM, Yim SH, Chung YJ. Copy Number Variations in the Human Genome: Potential Source for Individual Diversity and Disease Association Studies. Genomics Inform 2008. [DOI: 10.5808/gi.2008.6.1.001] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
18
|
Sung JH, Lee MK, Seo JS. Inbreeding Coefficients in Two Isolated Mongolian Populations - GENDISCAN Study. Genomics Inform 2008. [DOI: 10.5808/gi.2008.6.1.014] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
19
|
Liu F, Arias-Vásquez A, Sleegers K, Aulchenko YS, Kayser M, Sanchez-Juan P, Feng BJ, Bertoli-Avella AM, van Swieten J, Axenovich TI, Heutink P, van Broeckhoven C, Oostra BA, van Duijn CM. A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population. Am J Hum Genet 2007; 81:17-31. [PMID: 17564960 PMCID: PMC1950931 DOI: 10.1086/518720] [Citation(s) in RCA: 116] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2007] [Accepted: 03/27/2007] [Indexed: 12/30/2022] Open
Abstract
Alzheimer disease (AD) is the most common cause of dementia. We conducted a genome screen of 103 patients with late-onset AD who were ascertained as part of the Genetic Research in Isolated Populations (GRIP) program that is conducted in a recently isolated population from the southwestern area of The Netherlands. All patients and their 170 closely related relatives were genotyped using 402 microsatellite markers. Extensive genealogy information was collected, which resulted in an extremely large and complex pedigree of 4,645 members. The pedigree was split into 35 subpedigrees, to reduce the computational burden of linkage analysis. Simulations aiming to evaluate the effect of pedigree splitting on false-positive probabilities showed that a LOD score of 3.64 corresponds to 5% genomewide type I error. Multipoint analysis revealed four significant and one suggestive linkage peaks. The strongest evidence of linkage was found for chromosome 1q21 (heterogeneity LOD [HLOD]=5.20 at marker D1S498). Approximately 30 cM upstream of this locus, we found another peak at 1q25 (HLOD=4.0 at marker D1S218). These two loci are in a previously established linkage region. We also confirmed the AD locus at 10q22-24 (HLOD=4.15 at marker D10S185). There was significant evidence of linkage of AD to chromosome 3q22-24 (HLOD=4.44 at marker D3S1569). For chromosome 11q24-25, there was suggestive evidence of linkage (HLOD=3.29 at marker D11S1320). We next tested for association between cognitive function and 4,173 single-nucleotide polymorphisms in the linked regions in an independent sample consisting of 197 individuals from the GRIP region. After adjusting for multiple testing, we were able to detect significant associations for cognitive function in four of five AD-linked regions, including the new region on chromosome 3q22-24 and regions 1q25, 10q22-24, and 11q25. With use of cognitive function as an endophenotype of AD, our study indicates the that the RGSL2, RALGPS2, and C1orf49 genes are the potential disease-causing genes at 1q25. Our analysis of chromosome 10q22-24 points to the HTR7, MPHOSPH1, and CYP2C cluster. This is the first genomewide screen that showed significant linkage to chromosome 3q23 markers. For this region, our analysis identified the NMNAT3 and CLSTN2 genes. Our findings confirm linkage to chromosome 11q25. We were unable to confirm SORL1; instead, our analysis points to the OPCML and HNT genes.
Collapse
Affiliation(s)
- Fan Liu
- Genetic Epidemiology Unit, Department of Epidemiology and Biostatistics and Clinical Genetics, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Pattaro C, Marroni F, Riegler A, Mascalzoni D, Pichler I, Volpato CB, Dal Cero U, De Grandi A, Egger C, Eisendle A, Fuchsberger C, Gögele M, Pedrotti S, Pinggera GK, Stefanov SA, Vogl FD, Wiedermann CJ, Meitinger T, Pramstaller PP. The genetic study of three population microisolates in South Tyrol (MICROS): study design and epidemiological perspectives. BMC MEDICAL GENETICS 2007; 8:29. [PMID: 17550581 PMCID: PMC1913911 DOI: 10.1186/1471-2350-8-29] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/30/2006] [Accepted: 06/05/2007] [Indexed: 11/10/2022]
Abstract
BACKGROUND There is increasing evidence of the important role that small, isolated populations could play in finding genes involved in the etiology of diseases. For historical and political reasons, South Tyrol, the northern most Italian region, includes several villages of small dimensions which remained isolated over the centuries. METHODS The MICROS study is a population-based survey on three small, isolated villages, characterized by: old settlement; small number of founders; high endogamy rates; slow/null population expansion. During the stage-1 (2002/03) genealogical data, screening questionnaires, clinical measurements, blood and urine samples, and DNA were collected for 1175 adult volunteers. Stage-2, concerning trait diagnoses, linkage analysis and association studies, is ongoing. The selection of the traits is being driven by expert clinicians. Preliminary, descriptive statistics were obtained. Power simulations for finding linkage on a quantitative trait locus (QTL) were undertaken. RESULTS Starting from participants, genealogies were reconstructed for 50,037 subjects, going back to the early 1600s. Within the last five generations, subjects were clustered in one pedigree of 7049 subjects plus 178 smaller pedigrees (3 to 85 subjects each). A significant probability of familial clustering was assessed for many traits, especially among the cardiovascular, neurological and respiratory traits. Simulations showed that the MICROS pedigree has a substantial power to detect a LOD score > or = 3 when the QTL specific heritability is > or = 20%. CONCLUSION The MICROS study is an extensive, ongoing, two-stage survey aimed at characterizing the genetic epidemiology of Mendelian and complex diseases. Our approach, involving different scientific disciplines, is an advantageous strategy to define and to study population isolates. The isolation of the Alpine populations, together with the extensive data collected so far, make the MICROS study a powerful resource for the study of diseases in many fields of medicine. Recent successes and simulation studies give us confidence that our pedigrees can be valuable both in finding new candidates loci and to confirm existing candidate genes.
Collapse
Affiliation(s)
| | - Fabio Marroni
- Institute of Genetic Medicine, European Academy, Bolzano, Italy
| | - Alice Riegler
- Institute of Genetic Medicine, European Academy, Bolzano, Italy
| | | | - Irene Pichler
- Institute of Genetic Medicine, European Academy, Bolzano, Italy
| | | | | | | | - Clemens Egger
- Institute of Genetic Medicine, European Academy, Bolzano, Italy
| | - Agatha Eisendle
- Institute of Genetic Medicine, European Academy, Bolzano, Italy
| | | | - Martin Gögele
- Institute of Genetic Medicine, European Academy, Bolzano, Italy
| | - Sara Pedrotti
- Institute of Genetic Medicine, European Academy, Bolzano, Italy
| | - Gerd K Pinggera
- Institute of Genetic Medicine, European Academy, Bolzano, Italy
| | | | - Florian D Vogl
- Department of Gynaecology, Hospital of Merano, Via Rossini 5, 39012 Merano-Meran, Italy
| | - Christian J Wiedermann
- Laboratory of Medical Intensive Care, Division of General Internal Medicine, Department of Medicine, Medical University of Innsbruck, Innsbruck, Austria
- Division of Internal Medicine II, Department of Medicine, Central Hospital of Bolzano, Bolzano/Bozen, Italy
| | - Thomas Meitinger
- Institute of Human Genetics, Technical University of Munich, Munich, Germany
- GSF – National Research Center for Environment and Health, Institute of Human Genetics, München-Neuherberg, Germany
| | - Peter P Pramstaller
- Institute of Genetic Medicine, European Academy, Bolzano, Italy
- Department of Neurology, University of Lübeck, Lübeck, Germany
- Department of Neurology, General Regional Hospital, Bolzano, Italy
| |
Collapse
|
21
|
Parsons MJ, Mata I, Beperet M, Iribarren-Iriso F, Arroyo B, Sainz R, Arranz MJ, Kerwin R. A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate. Psychiatr Genet 2007; 17:159-63. [PMID: 17417059 DOI: 10.1097/ypg.0b013e328017f8a4] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Numerous lines of evidence have highlighted the involvement of the dopamine system in the pathophysiology of schizophrenia. Association studies of dopaminergic genes such as the dopamine D2 receptor gene (DRD2), however, have produced contradictory results. To test the hypothesis that DRD2 polymorphisms are associated with schizophrenia, we investigated two DRD2-related polymorphisms (TaqI A1/A2 or rs1800497 and -141-C Ins/Del or rs1799732) in a Spanish population isolate from northern Spain consisting of 165 controls and 119 patients with schizophrenia. The TaqI A1 allele was less frequent in schizophrenic patients than in controls (P=0.002). A similar association was found for the TaqI A2/A2 genotype (P=0.0003). No association was found for the DRD2 -141-C Ins/Del polymorphism. The strong association between a potentially functional polymorphism, downstream of the DRD2 gene and schizophrenia, suggests that the direct or indirect functional effects of this polymorphism, acting on either the ANKK1 or DRD2 genes, may play a role in the pathophysiology of schizophrenia.
Collapse
Affiliation(s)
- Michael J Parsons
- Clinical Neuropharmacology, Institute of Psychiatry, KCL, London, UK.
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Demographic changes and marker properties affect detection of human population differentiation. BMC Genet 2007; 8:21. [PMID: 17498298 PMCID: PMC1876243 DOI: 10.1186/1471-2156-8-21] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2006] [Accepted: 05/11/2007] [Indexed: 01/02/2023] Open
Abstract
BACKGROUND Differentiating genetically between populations is valuable for admixture and population stratification detection and in understanding population history. This is easy to achieve for major continental populations, but not for closely related populations. It has been claimed that a large marker panel is necessary to reliably distinguish populations within a continent. We investigated whether empirical genetic differentiation could be accomplished efficiently among three Asian populations (Hmong, Thai, and Chinese) using a small set of highly variable markers (15 tetranucleotide and 17 dinucleotide repeats). RESULTS Hmong could be differentiated from Thai and Chinese based on multi-locus genotypes, but Thai and Chinese were indistinguishable from each other. We found significant evidence for a recent population bottleneck followed by expansion in the Hmong that was not present in the Thai or Chinese. Tetranucleotide repeats were less useful than dinucleotide repeat markers in distinguishing between major continental populations (Asian, European, and African) while both successfully distinguished Hmong from Thai and Chinese. CONCLUSION Demographic history contributes significantly to robust detection of intracontinental population structure. Populations having experienced a rapid size reduction may be reliably distinguished as a result of a genetic drift -driven redistribution of population allele frequencies. Tetranucleotide markers, which differ from dinucleotide markers in mutation mechanism and rate, are similar in information content to dinucleotide markers in this situation. These factors should be considered when identifying populations suitable for gene mapping studies and when interpreting interpopulation relationships based on microsatellite markers.
Collapse
|
23
|
Lee BD, Walss-Bass C, Thompson PM, Dassori A, Montero PA, Medina R, Contreras S, Armas R, Ramirez M, Pereira M, Salazar R, Leach RJ, Quezada P, Raventos H, Escamilla MA. Malic enzyme 2 and susceptibility to psychosis and mania. Psychiatry Res 2007; 150:1-11. [PMID: 17258816 DOI: 10.1016/j.psychres.2006.06.001] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/03/2006] [Revised: 04/12/2006] [Accepted: 06/08/2006] [Indexed: 01/29/2023]
Abstract
Previous studies have identified a putative gene locus for both schizophrenia and bipolar disorder in the chromosome 18q21 region. To identify candidate genes associated with these disorders we completed fine mapping analyses (using microsatellite markers) in 152 families from the Central Valley of Costa Rica (CVCR) (376 total subjects, 151 with a history of psychosis, 97 with a history of mania). Microsatellite analyses showed evidence of association at two contiguous markers, both located at the same genetic distance and spanning approximately 11 known genes. In a corollary gene expression study, one of these genes, malic enzyme 2 (ME2), showed levels of gene expression 5.6-fold lower in anterior cingulate tissue from post-mortem bipolar brains. Subsequent analysis of individual SNPs in strong linkage disequilibrium with the ME2 gene revealed one SNP and one haplotype associated with the phenotype of psychosis in the CVCR sample. ME2 interacts directly with the malate shuttle system, which has been shown to be altered in schizophrenia and bipolar disorder, and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid. The present study suggests that genetic variation in or near the ME2 gene is associated with both psychotic and manic disorders, including schizophrenia and bipolar disorder.
Collapse
Affiliation(s)
- Byung Dae Lee
- Psychiatric Genetics Research Center, Department of Psychiatry, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Marroni F, Pichler I, De Grandi A, Volpato CB, Vogl FD, Pinggera GK, Bailey-Wilson JE, Pramstaller PP. Population isolates in South Tyrol and their value for genetic dissection of complex diseases. Ann Hum Genet 2006; 70:812-21. [PMID: 17044856 DOI: 10.1111/j.1469-1809.2006.00274.x] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The study of genetic isolates is a promising approach for the study of complex genetic traits. The small and constant population size, lack of migration, and multiple relationships between individuals in the isolate population could reduce the genetic diversity, and lead to increased levels of linkage disequilibrium (LD). We studied the extent of LD on Xq13 in six population isolates from South Tyrol in the Eastern Italian Alps. We found different levels of LD in our study samples, probably reflecting their degrees of isolation and their demographic histories. The highest values were obtained in Val Gardena (ranking among the highest levels of LD in Europe) and in Stelvio, which qualified as a microisolate according to historical information, and biodemographic and genealogical criteria. Phylogenetic analysis revealed that the two Ladin-speaking populations are genetically distant from each other, and from their German-speaking neighbours, and are characterized by a smaller effective population size than the neighbouring valleys. These peculiar characteristics suggest that South Tyrol could be a unique resource for the study of complex diseases, showing all the characteristics of isolated populations with the advantage of including, in a fairly homogeneous environment, two genetically differentiated sub-populations. This could allow investigators to gain an insight into the contribution of genetic heterogeneity in complex diseases.
Collapse
Affiliation(s)
- F Marroni
- Institute of Genetic Medicine, European Academy of Bolzano, Viale Druso 1, 39100 Bolzano-Bozen, Italy
| | | | | | | | | | | | | | | |
Collapse
|
25
|
Tomàs C, Cañellas F, Rodríguez V, Picornell A, Lafau O, Nadal M, Roca M, Serrano MJ, Castro JA, Ramon MM. Genetic linkage study for bipolar disorders on chromosomes 17 and 18 in families with a high expression of mental illness from the Balearic Islands. Psychiatr Genet 2006; 16:145-51. [PMID: 16829781 DOI: 10.1097/01.ypg.0000218614.42762.b0] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Genetically, bipolar disorder is a complex genetic illness, in which both genes and environmental factors play an important role in pathogenesis. Linkage studies have reported suggestive evidence for genomic regions, especially on chromosome 18, but in most cases they have been inconclusive. A total of 12 pedigrees, from the islands of Majorca and Minorca (Balearic Archipelago), with a high expression of mental illness, have been studied. A scan of 29 polymorphic short tandem repeat markers was performed, spanning chromosomes 17 and 18 for bipolar and other affective disorder susceptibility loci. Narrow (only bipolar I disorder) and broad (bipolar plus other affective disorders) diagnosis criteria were employed. The loci D18S63, D18S452, D18S53, D18S61, D18S1161 and D17S831 showed LOD score values of less than -2. Thus, the positive linkage found by other authors on the regions 18p11.2 and 18p11.3 has not been reproduced in the families studied. The data obtained in chromosome 17 suggested two possible regions that could contain a bipolar disorder susceptibility gene: 17q11 (D17S1857, D17S798) and especially 17q24-qter (D17S949, D17S928). The maximum significant linkage was to D17S949 (17q24), following a recessive mode of inheritance. We have also found a positive LOD score value for D18S478 marker located in the region 18q12.
Collapse
Affiliation(s)
- Carmen Tomàs
- Laboratory of Genetics, Department of Biology, University Institute of Health Sciences (IUNICS), and Juan March Hospital, Palma de Mallorca, Spain
| | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Walss-Bass C, Montero AP, Armas R, Dassori A, Contreras SA, Liu W, Medina R, Levinson D, Pereira M, Atmella I, NeSmith L, Leach R, Almasy L, Raventos H, Escamilla MA. Linkage disequilibrium analyses in the Costa Rican population suggests discrete gene loci for schizophrenia at 8p23.1 and 8q13.3. Psychiatr Genet 2006; 16:159-68. [PMID: 16829783 DOI: 10.1097/01.ypg.0000218616.27515.67] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Linkage studies using multiplex families have repeatedly implicated chromosome 8 as involved in schizophrenia etiology. The reported areas of linkage, however, span a wide chromosomal region. The present study used the founder population of the Central Valley of Costa Rica and phenotyping strategies alternative to DSM-IV classifications in attempts to further delimitate the areas on chromosome 8 that may harbor schizophrenia susceptibility genes. A linkage disequilibrium screen of chromosome 8 was performed using family trios of individuals with a history of psychosis. Four discrete regions showing evidence of association (nominal P values less than 0.05) to the phenotype of schizophrenia were identified: 8p23.1, 8p21.3, 8q13.3 and 8q24.3. The region of 8p23.1 precisely overlaps a region showing strong evidence of linkage disequilibrium for severe bipolar disorder in Costa Rica. The same chromosomal regions were identified when the broader phenotype definition of all individuals with functional psychosis was used for analyses. Stratification of the psychotic sample by history of mania suggests that the 8q13.3 locus may be preferentially associated with non-manic psychosis. These results may be helpful in targeting specific areas to be analyzed in association-based or linkage disequilibrium-based studies, for researchers who have found evidence of linkage to schizophrenia on chromosome 8 within their previous studies.
Collapse
Affiliation(s)
- Consuelo Walss-Bass
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, and Southwest Foundation for Biomedical Research, San Antonio, Texas 78229-3900, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Bourgain C, Génin E. Complex trait mapping in isolated populations: Are specific statistical methods required? Eur J Hum Genet 2005; 13:698-706. [PMID: 15785775 DOI: 10.1038/sj.ejhg.5201400] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
In this paper, we review the statistical methods that can be used in isolated populations to map genes involved in complex diseases. Our intention is to highlight the fact that if the features of population isolates may help in the identification of susceptibility factors for complex traits, the choice and design of methods for statistical analysis in these populations deserve particular care. We show that methods designed for outbred samples are generally not appropriate for isolated populations and could lead to false conclusions.
Collapse
|
28
|
Shink E, Morissette J, Sherrington R, Barden N. A genome-wide scan points to a susceptibility locus for bipolar disorder on chromosome 12. Mol Psychiatry 2005; 10:545-52. [PMID: 15494705 DOI: 10.1038/sj.mp.4001601] [Citation(s) in RCA: 58] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Our previous results pointed to a putative gene for susceptibility to bipolar affective disorder located on the chromosomal region 12q23-q24 that segregated in the Saguenay-Lac-St-Jean population of Quebec. We report here results from a second genome-wide scan based on the analysis of 380 polymorphic microsatellite markers. For the purpose of this analysis, an additional 18 families were recruited from the Saguenay-Lac-St-Jean region and pooled to our previous sample to improve its statistical power, giving a total of 394 sampled individuals. This work confirms the presence of a susceptibility locus for affective disorder on chromosome 12q24 with parametric LOD score value of 3.35 at D12S378 when pedigrees were broken into nuclear families and analysed under a recessive segregation model. This result was supported by neighbouring markers and by a LOD score value of 5.05 at D12S378 under model-free analysis. Other regions of lower interest were indicated on chromosomes 2, 5, 7, 9, 10, 17 and 20.
Collapse
Affiliation(s)
- E Shink
- Neuroscience, CHUL Research Centre and Laval University, CHUQ Pavillon CHUL, Ste-Foy, Québec, Canada
| | | | | | | |
Collapse
|
29
|
Carmeli DB. Prevalence of Jews as subjects in genetic research: figures, explanation, and potential implications. Am J Med Genet A 2004; 130A:76-83. [PMID: 15368499 DOI: 10.1002/ajmg.a.20291] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Geneticists' view of 'population isolates' as bearing special utility for research often translates into the targeting of such groups as study populations. This paper aims to outline the prevalence and structure of reference to one such group-that of the Jews-in genetic research publications. The paper uses three prevalence scores, calculated on the basis of a search of the PubMed database, conducted in September-October 2002. A systematic comparison to other population groups shows that in relation to the population size and in relation to the general bioscientific reference to this group, Jews are over-represented in human genetic literature, particularly in mutation-related contexts. This pattern is interpreted as representing geneticists' interest in Jewish communities, which are comparatively endogamous yet sizeable. It is also attributed to geneticists' access to Jewish communities, which is facilitated by the participation of Jewish scientists that alleviates ethical concerns as well. The geographical proximity of the largest Jewish communities to major research centers, and previous acquaintance with the genetic paradigm that many Jewish persons possess, further enhance this trend. The paper ends by pointing at potential extra-medical implications of this increased prevalence.
Collapse
|
30
|
Mathews CA, Reus VI, Bejarano J, Escamilla MA, Fournier E, Herrera LD, Lowe TL, McInnes LA, Molina J, Ophoff RA, Raventos H, Sandkuijl LA, Service SK, Spesny M, León PE, Freimer NB. Genetic studies of neuropsychiatric disorders in Costa Rica: a model for the use of isolated populations. Psychiatr Genet 2004; 14:13-23. [PMID: 15091311 DOI: 10.1097/00041444-200403000-00003] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
The importance of genetics in understanding the etiology of mental illness has become increasingly clear in recent years, as more evidence has mounted that almost all neuropsychiatric disorders have a genetic component. It has also become clear, however, that these disorders are etiologically complex, and multiple genetic and environmental factors contribute to their makeup. So far, traditional linkage mapping studies have not definitively identified specific disease genes for neuropsychiatric disorders, although some potential candidates have been identified via these methods (e.g. the dysbindin gene in schizophrenia; Straub et al., 2002; Schwab et al., 2003). For this reason, alternative approaches are being attempted, including studies in genetically isolated populations. Because isolated populations have a high degree of genetic homogeneity, their use may simplify the process of identifying disease genes in disorders where multiple genes may play a role. Several areas of Latin America contain genetically isolated populations that are well suited for the study of neuropsychiatric disorders. Genetic studies of several major psychiatric illnesses, including bipolar disorder, major depression, schizophrenia, Tourette Syndrome, alcohol dependence, attention deficit hyperactivity disorder, and obsessive-compulsive disorder, are currently underway in these regions. In this paper we highlight the studies currently being conducted by our groups in the Central Valley of Costa Rica to illustrate the potential advantages of this population for genetic studies.
Collapse
Affiliation(s)
- Carol A Mathews
- Department of Psychiatry, University of California, San Diego, La Jolla, CA 92093-0810, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Fallin MD, Lasseter VK, Wolyniec PS, McGrath JA, Nestadt G, Valle D, Liang KY, Pulver AE. Genomewide linkage scan for bipolar-disorder susceptibility loci among Ashkenazi Jewish families. Am J Hum Genet 2004; 75:204-19. [PMID: 15208783 PMCID: PMC1216055 DOI: 10.1086/422474] [Citation(s) in RCA: 75] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2004] [Accepted: 05/10/2004] [Indexed: 01/22/2023] Open
Abstract
The relatively short history of linkage studies in bipolar disorders (BPs) has produced inconsistent findings. Implicated regions have been large, with reduced levels of significance and modest effect sizes. Both phenotypic and genetic heterogeneity may have contributed to the failure to define risk loci. BP is part of a spectrum of apparently familial affective disorders, which have been organized by severity. Heterogeneity may arise because of insufficient data to define the spectrum boundaries, and, in general, the less-severe disorders are more difficult to diagnose reliably. To address the inherent complexities in detecting BP susceptibility loci, we have used restricted diagnostic classifications and a genetically more homogeneous (Ashkenazi Jewish) family collection to perform a 9-cM autosomal genomewide linkage scan. Although they are genetically more homogeneous, there are no data to suggest that the rate of illness in the Ashkenazim differs from that in other populations. In a genome scan of 41 Ashkenazi pedigrees with a proband affected with bipolar I disorder (BPI) and at least one other member affected with BPI or bipolar II disorder (BPII), we identified four regions suggestive of linkage on chromosomes 1, 3, 11, and 18. Follow-up genotyping showed that the regions on chromosomes 1, 3, and 18 are also suggestive of linkage in a subset of pedigrees limited to relative pairs affected with BPI. Furthermore, our chromosome 18q22 signal (D18S541 and D18S477) overlaps with previous BP findings. This research is being conducted in parallel with our companion study of schizophrenia, in which, by use of an identical approach, we recently reported significant evidence for a schizophrenia susceptibility locus in the Ashkenazim on chromosome 10q22.
Collapse
Affiliation(s)
- M. Daniele Fallin
- Departments of Epidemiology and Biostatistics, Johns Hopkins Bloomberg School of Public Health, and Departments of Psychiatry & Behavioral Sciences, Pediatrics, Molecular Biology, and Genetics, Howard Hughes Medical Institute, and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore
| | - Virginia K. Lasseter
- Departments of Epidemiology and Biostatistics, Johns Hopkins Bloomberg School of Public Health, and Departments of Psychiatry & Behavioral Sciences, Pediatrics, Molecular Biology, and Genetics, Howard Hughes Medical Institute, and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore
| | - Paula S. Wolyniec
- Departments of Epidemiology and Biostatistics, Johns Hopkins Bloomberg School of Public Health, and Departments of Psychiatry & Behavioral Sciences, Pediatrics, Molecular Biology, and Genetics, Howard Hughes Medical Institute, and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore
| | - John A. McGrath
- Departments of Epidemiology and Biostatistics, Johns Hopkins Bloomberg School of Public Health, and Departments of Psychiatry & Behavioral Sciences, Pediatrics, Molecular Biology, and Genetics, Howard Hughes Medical Institute, and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore
| | - Gerald Nestadt
- Departments of Epidemiology and Biostatistics, Johns Hopkins Bloomberg School of Public Health, and Departments of Psychiatry & Behavioral Sciences, Pediatrics, Molecular Biology, and Genetics, Howard Hughes Medical Institute, and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore
| | - David Valle
- Departments of Epidemiology and Biostatistics, Johns Hopkins Bloomberg School of Public Health, and Departments of Psychiatry & Behavioral Sciences, Pediatrics, Molecular Biology, and Genetics, Howard Hughes Medical Institute, and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore
| | - Kung-Yee Liang
- Departments of Epidemiology and Biostatistics, Johns Hopkins Bloomberg School of Public Health, and Departments of Psychiatry & Behavioral Sciences, Pediatrics, Molecular Biology, and Genetics, Howard Hughes Medical Institute, and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore
| | - Ann E. Pulver
- Departments of Epidemiology and Biostatistics, Johns Hopkins Bloomberg School of Public Health, and Departments of Psychiatry & Behavioral Sciences, Pediatrics, Molecular Biology, and Genetics, Howard Hughes Medical Institute, and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore
| |
Collapse
|
32
|
Schulze TG, McMahon FJ. Genetic linkage and association studies in bipolar affective disorder: a time for optimism. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS 2004; 123C:36-47. [PMID: 14601035 DOI: 10.1002/ajmg.c.20012] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Genetic research on complex diseases is beginning to bear fruit, with the successful identification of candidate susceptibility genes in diabetes, asthma, and other illnesses. Similar success is on the horizon for bipolar affective disorder (BPAD), but significant challenges remain. In this review, we outline the basic concepts of linkage and association mapping for complex phenotypes. We point out important caveats inherent in both approaches, and review guidelines on the interpretation of linkage statistics and significance thresholds. We then apply these concepts to an evaluation of the present status of genetic linkage and association studies in BPAD. The challenges posed by locus heterogeneity, phenotype definition, and sample size requirements are given a detailed treatment. Despite these challenges, we argue that the way ahead remains firmly rooted in linkage studies, complemented by association studies in linked regions. This is the only truly genome-wide approach currently available; it has succeeded in other complex phenotypes, and it is the surest strategy for mapping susceptibility genes in BPAD. Once these genes are identified, genetic mapping methods will yield to the other methods of 21st-century molecular biology as we begin to elucidate the pathophysiology of BPAD.
Collapse
Affiliation(s)
- Thomas G Schulze
- Division of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany.
| | | |
Collapse
|
33
|
Birenbaum-Carmeli D. On the prevalence of population groups in the human-genetics research literature. Politics Life Sci 2004; 23:34-41. [PMID: 16859378 DOI: 10.2990/1471-5457(2004)23[34:otpopg]2.0.co;2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/11/2023]
Abstract
BACKGROUND Population-specific human-genetics research has become commonplace but remains controversial, as its results can affect public and personal perceptions of the ethnic, national, and racial groups studied. Choice of populations for study has generally seemed a function of scientific, logistical, or economic factors. RESEARCH QUESTION Has the identity of populations studied in the human-genetics research literature varied systematically, and, if it has, in what ways? METHODS I searched the PubMed database for population-genetics reports, calculating for each a population score, a genetics score, and a mutation score. RESULTS Some populations had been studied far more intensively than others. Many of the most frequently studied groups were ethnically defined and politically marginal in their home countries; some of these groups were involved in self-determination struggles. In the mutation-research literature, state-defined Muslim and Mediterranean populations prevailed. CONCLUSION Study-population selection may in some cases be explained by, or may complicate, political predicament.
Collapse
|
34
|
Abstract
Bipolar disorder is an etiologically complex syndrome that is clearly heritable. Multiple genes, working singly or in concert, are likely to cause susceptibility to bipolar disorder. Bipolar disorder genetics has progressed rapidly in the last few decades. However, specific causal genetic mutations for bipolar disorder have not been identified. Both candidate gene studies and complete genome screens have been conducted. They have provided compelling evidence for several potential bipolar disorder susceptibility loci in several regions of the genome. The strongest evidence suggests that bipolar disorder susceptibility loci may lie in one or more genomic regions on chromosomes 18, 4, and 21. Other regions of interest, including those on chromosomes 5 and 8, are also under investigation. New approaches, such as the use of genetically isolated populations and the use of endophenotypes for bipolar disorder, hold promise for continued advancement in the search to identify specific bipolar disorder genes.
Collapse
Affiliation(s)
- Carol A Mathews
- Department of Psychiatry at the University of California, San Diego, San Diego, California, USA
| | | |
Collapse
|
35
|
Zak NB, Pisanté-Shalom A, Darvasi A. Population-based gene discovery in psychiatric diseases. Expert Rev Neurother 2003; 3:51-7. [DOI: 10.1586/14737175.3.1.51] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
36
|
Shifman S, Bronstein M, Sternfeld M, Pisanté-Shalom A, Lev-Lehman E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, Schiffer R, Kotler M, Strous RD, Swartz-Vanetik M, Knobler HY, Shinar E, Beckmann JS, Yakir B, Risch N, Zak NB, Darvasi A. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 2002; 71:1296-302. [PMID: 12402217 PMCID: PMC378567 DOI: 10.1086/344514] [Citation(s) in RCA: 553] [Impact Index Per Article: 25.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2002] [Accepted: 08/28/2002] [Indexed: 11/03/2022] Open
Abstract
Several lines of evidence have placed the catechol-O-methyltransferase (COMT) gene in the limelight as a candidate gene for schizophrenia. One of these is its biochemical function in metabolism of catecholamine neurotransmitters; another is the microdeletion, on chromosome 22q11, that includes the COMT gene and causes velocardiofacial syndrome, a syndrome associated with a high rate of psychosis, particularly schizophrenia. The interest in the COMT gene as a candidate risk factor for schizophrenia has led to numerous linkage and association analyses. These, however, have failed to produce any conclusive result. Here we report an efficient approach to gene discovery. The approach consists of (i) a large sample size-to our knowledge, the present study is the largest case-control study performed to date in schizophrenia; (ii) the use of Ashkenazi Jews, a well defined homogeneous population; and (iii) a stepwise procedure in which several single nucleotide polymorphisms (SNPs) are scanned in DNA pools, followed by individual genotyping and haplotype analysis of the relevant SNPs. We found a highly significant association between schizophrenia and a COMT haplotype (P=9.5x10-8). The approach presented can be widely implemented for the genetic dissection of other common diseases.
Collapse
Affiliation(s)
- Sagiv Shifman
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Michal Bronstein
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Meira Sternfeld
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Anne Pisanté-Shalom
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Efrat Lev-Lehman
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Avraham Weizman
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Ilya Reznik
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Baruch Spivak
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Nimrod Grisaru
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Leon Karp
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Richard Schiffer
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Moshe Kotler
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Rael D. Strous
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Marnina Swartz-Vanetik
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Haim Y. Knobler
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Eilat Shinar
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Jacques S. Beckmann
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Benjamin Yakir
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Neil Risch
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Naomi B. Zak
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| | - Ariel Darvasi
- Institute of Life Sciences and Department of Statistics, The Hebrew University of Jerusalem, IDgene Pharmaceuticals, and The Jerusalem Mental Health Center, Kfar Shaul Hospital, Jerusalem; Geha Psychiatric Hospital, Petach Tikva, Israel; Ness Ziona Medical Center, Ness Ziona, Israel; Mental Health Center, Ben-Gurion University of the Negev, Be’er Sheva, Israel; Lev Hasharon Community Mental Health Clinic, Pardesia, Israel; Mental Health Center Be’er Ya’akov, Be’er Ya’akov, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv; Abarbanel Mental Health Center, Bat Yam, Israel; Magen David Adom National Blood Services, Ramat Gan, Israel; Department of Molecular Genetics and Crown Genome Center, The Weizmann Institute of Science, Rehovot, Israel; and Department of Genetics, Stanford University School of Medicine, Stanford, CA
| |
Collapse
|